With Joe Biden heading to the White House, green stocks could see a good deal of upside. For one, "A Biden administration will mean more regulatory scrutiny for financial and energy stocks and probably higher taxes across the board," says Rodney Johnson, president of economic research firm HS Dent Publishing, as quoted by Kiplinger. "But there will be opportunities. Infrastructure spending,...
Continue reading >>The stock market closed higher on Friday despite a disappointing jobs report as Wall Street remained focused on positive vaccine developments and growing hopes for more fiscal stimulus before yearend. The gains lifted all four of the major indexes to fresh all-time highs, along with the Transports, with volatility continuing to hold a key level of support. The Russell 2000 finished on its...
Continue reading >>...
Continue reading >>Vaccine stocks continue to explode higher. Moderna (MRNA) has now from $72 to $172, as it nears its meeting with the US FDA on Dec. 17 with regards to emergency use authorization. BioNTech (BNTX) has run from $90 to $130 a share, as it also nears emergency use authorization with the US FDA. Even Pfizer (PFE) has run from $35 to $43. We’d like to see the PFE stock closer to $50 a share...
Continue reading >>...
Continue reading >>The stock market closed higher on Friday despite a disappointing jobs report as Wall Street remained focused on positive vaccine developments and growing hopes for more fiscal stimulus before yearend. The gains lifted all four of the major indexes to fresh all-time highs, along with the Transports, with volatility continuing to hold a key level of support. The Russell 2000 finished on its...
Continue reading >>